Epigenetic effects of natural polyphenols: A focus on SIRT1-mediated mechanisms

Molecular Nutrition and Food Research

Volumn 58, Issue 1, 2014, Pages 22-32

  Ayissi, Vincent B Owona ^a,b   Ebrahimi, Azadeh ^a,c   Schluesenner, Hermann ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b University of Yaoundé I   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Diet; Epigenetic; Inflammation; Natural polyphenols; SIRT1

Indexed keywords

ANTINEOPLASTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; POLYPHENOL; SIRT1 PROTEIN, HUMAN; SIRTUIN 1;

ADIPOGENESIS; AGING; CHEMISTRY; DEGENERATIVE DISEASE; DIET; DRUG EFFECT; EPIGENETIC; GENETIC EPIGENESIS; HUMAN; INFLAMMATION; LIPID METABOLISM; METABOLISM; NATURAL POLYPHENOLS; NEOPLASM; REVIEW; SIRT1; STRUCTURE ACTIVITY RELATION; VEGETABLE;

DIET; EPIGENETIC; INFLAMMATION; NATURAL POLYPHENOLS; SIRT1;

ADIPOGENESIS; AGING; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; EPIGENESIS, GENETIC; HUMANS; LIPID METABOLISM; NEOPLASMS; NEURODEGENERATIVE DISEASES; POLYPHENOLS; SIRTUIN 1; STRUCTURE-ACTIVITY RELATIONSHIP; VEGETABLES;

EID: 84891390364     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300195     Document Type: Review

References (111)

1. Korzus, E., Manipulating the brain with epigenetics. Nature Neurosci. 2010, 13, 405-406.
2. Kikuno, N., Shiina, H., Urakami, S., Kawamoto, K. et al., Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int. J. Cancer 2008, 123, 552-560.
3. Wang, Y., Wang, X., Liu, L., Wang, X., HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells. Neurosci. Lett. 2009, 467, 212-216.
4. Rahman, I., Chung, S., Dietary polyphenols, deacetylases and chromatin remodeling in inflammation. World Rev. Nutr. Diet. 2010, 101, 84-94.
5. Miyamoto, K., Ushijima, T., Diagnostic and therapeutic applications of epigenetics. Jap. J. Clin. Oncol. 2005, 35, 293-301.
6. Peedicayil, J., Epigenetic therapy: a new development in pharmacology. Indian J. Med. Res. 2006, 123, 17-24.
7. Cosio, B. G., Tsaprouni, L., Ito, K., Jazrawi, E. et al., Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J. Exp. Med. 2004, 200, 689-695.
8. Halliwell, B., Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001, 18, 685-716.
9. Williams, R. J., Spencer, J. P., Rice-Evans, C., Flavonoids: antioxidants or signalling molecules? Free Radical Biol. Med. 2004, 36, 838-849.
10. Rahman, I., Chung, S., Dietary polyphenols, deacetylases and chromatin remodeling in inflammation. J. Nutrigenet. Nutrigenom. 2010, 3, 220-230.
11. Schneider-Stock, R., Ghantous, A., Bajbouj, K., Saikali, M. et al., Epigenetic mechanisms of plant-derived anticancer drugs. Front. Biosci.: J. Virtual Lib. 2012, 17, 129-173.
12. Hardy, T. M., Tollefsbol, T. O., Epigenetic diet: impact on the epigenome and cancer. Epigenomics 2011, 3, 503-518.
13. Biswas, S., Rahman, I., Modulation of steroid activity in chronic inflammation: a novel anti-inflammatory role for curcumin. Mol. Nutr. Food Res. 2008, 52, 987-994.
14. Beckman, J. A., Creager, M. A., Libby, P., Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA: J. Am. Med. Assoc. 2002, 287, 2570-2581.
15. Visconti, R., Grieco, D., New insights on oxidative stress in cancer. Curr. Opin. Drug Disc. Dev. 2009, 12, 240-245.
16. Zawia, N. H., Lahiri, D. K., Cardozo-Pelaez, F., Epigenetics, oxidative stress, and Alzheimer disease. Free Radical Biol. Med. 2009, 46, 1241-1249.
17. Johnstone, S. E., Baylin, S. B., Stress and the epigenetic landscape: a link to the pathobiology of human diseases? Nature Rev. Genetics 2010, 11, 806-812.
18. Suchankova, G., Nelson, L. E., Gerhart-Hines, Z., Kelly, M. et al., Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem. Biophys. Res. Commun. 2009, 378, 836-841.
19. Borra, M. T., Smith, B. C., Denu, J. M., Mechanism of human SIRT1 activation by resveratrol. J. Biol. Chem. 2005, 280, 17187-17195.
20. Sundaresan, N. R., Gupta, M., Kim, G., Rajamohan, S. B. et al., Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J. Clin. Invest. 2009, 119, 2758-2771.
21. Cavet, M. E., Harrington, K. L., Vollmer, T. R., Ward, K. W. et al., Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells. Mol. Vis. 2011, 17, 533-542.
22. Collett, G. P., Campbell, F. C., Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis 2004, 25, 2183-2189.
23. Alcain, F. J., Villalba, J. M., Sirtuin activators. Expert Opin. Therap. Patents 2009, 19, 403-414.
24. Biesalski, H. K., Polyphenols and inflammation: basic interactions. Curr. Opin. Clin. Nutr. Metab. Care 2007, 10, 724-728.
25. Choi, K. C., Jung, M. G., Lee, Y. H., Yoon, J. C. et al., Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res. 2009, 69, 583-592.
26. Yun, J. M., Jialal, I., Devaraj, S., Effects of epigallocatechin gallate on regulatory T cell number and function in obese v. lean volunteers. British J. Nutr. 2010, 103, 1771-1777.
27. Hong, K. S., Park, J. I., Kim, M. J., Kim, H. B. et al., Involvement of SIRT1 in hypoxic down-regulation of c-Myc and beta-catenin and hypoxic preconditioning effect of polyphenols. Toxicol. Appl. Pharmacol. 2012, 259, 210-218.
28. Kriegl, L., Vieth, M., Kirchner, T., Menssen, A., Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer. Oncotarget 2012, 3, 1182-1193.
29. Zygmunt, K., Faubert, B., MacNeil, J., Tsiani, E., Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK. Biochem. Biophys. Res. Commun. 2010, 398, 178-183.
30. Davis, J. M., Murphy, E. A., Carmichael, M. D., Davis, B., Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am. J. Physiol. Reg. Integrat. Comparat. Physiol. 2009, 296, R1071-R1077.
31. Kim, Y. H., Lee, D. H., Jeong, J. H., Guo, Z. S. et al., Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway. Biochem. Pharmacol. 2008, 75, 1946-1958.
32. Zhou, B., Wu, L. J., Tashiro, S., Onodera, S. et al., Protective effect of silibinin against isoproterenol-induced injury to cardiac myocytes and its mechanism. Yao xue xue bao = Acta Pharmaceutica Sinica 2007, 42, 263-268.
33. Hou, X., Xu, S., Maitland-Toolan, K. A., Sato, K. et al., SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem. 2008, 283, 20015-20026.
34. Marfe, G., Tafani, M., Indelicato, M., Sinibaldi-Salimei, P. et al., Kaempferol induces apoptosis in two different cell lines via Akt inactivation, Bax and SIRT3 activation, and mitochondrial dysfunction. J. Cell. Biochem. 2009, 106, 643-650.
35. Rasbach, K. A., Schnellmann, R. G., Isoflavones promote mitochondrial biogenesis. J. Pharmacol. Exp. Therap. 2008, 325, 536-543.
36. Longpre, F., Garneau, P., Christen, Y., Ramassamy, C., Protection by EGb 761 against beta-amyloid-induced neurotoxicity: involvement of NF-kappaB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation. Free Radical Biol. Med. 2006, 41, 1781-1794.
37. Yang, H., Baur, J. A., Chen, A., Miller, C. et al., Design and synthesis of compounds that extend yeast replicative lifespan. Aging Cell 2007, 6, 35-43.
38. Wang, L., Zhang, L., Chen, Z. B., Wu, J. Y. et al., Icariin enhances neuronal survival after oxygen and glucose deprivation by increasing SIRT1. Eur. J. Pharmacol. 2009, 609, 40-44.
39. Sunagawa, T., Shimizu, T., Kanda, T., Tagashira, M. et al., Procyanidins from apples (Malus pumila Mill.) extend the lifespan of Caenorhabditis elegans. Planta medica 2011, 77, 122-127.
40. Chung, S., Yao, H., Caito, S., Hwang, J. W. et al., Regulation of SIRT1 in cellular functions: role of polyphenols. Archives Biochem. Biophys. 2010, 501, 79-90.
41. Xiang, L., Sun, K., Lu, J., Weng, Y. et al., Anti-aging effects of phloridzin, an apple polyphenol, on yeast via the SOD and Sir2 genes. Biosci. Biotechnol. Biochem. 2011, 75, 854-858.
42. Dewa, Y., Nishimura, J., Jin, M., Kawai, M. et al., Molecular expression analysis of beta-naphthoflavone-induced hepatocellular tumors in rats. Toxicol. Pathol. 2009, 37, 446-455.
43. Wu, Y., Li, X., Zhu, J. X., Xie, W. et al., Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson's disease. Neuro-Signals 2011, 19, 163-174.
44. Abel, T., Zukin, R. S., Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr. Opin. Pharmacol. 2008, 8, 57-64.
45. Priyadarsini, R. V., Vinothini, G., Murugan, R. S., Manikandan, P. et al., The flavonoid quercetin modulates the hallmark capabilities of hamster buccal pouch tumors. Nutr. Cancer 2011, 63, 218-226.
46. Kahyo, T., Ichikawa, S., Hatanaka, T., Yamada, M. K. et al., A novel chalcone polyphenol inhibits the deacetylase activity of SIRT1 and cell growth in HEK293T cells. J. Pharmacol. Sci. 2008, 108, 364-371.
47. Nandakumar, V., Vaid, M., Katiyar, S. K., (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 2011, 32, 537-544.
48. Attoub, S., Hassan, A. H., Vanhoecke, B., Iratni, R. et al., Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. Eur. J. Pharmacol. 2011, 651, 18-25.
49. Kang, S. K., Cha, S. H., Jeon, H. G., Curcumin-induced histone hypoacetylation enhances caspase-3-dependent glioma cell death and neurogenesis of neural progenitor cells. Stem cells Dev. 2006, 15, 165-174.
50. Jones, P. A., Baylin, S. B., The fundamental role of epigenetic events in cancer. Nature Rev. Genetics 2002, 3, 415-428.
51. Choudhury, S. R., Balasubramanian, S., Chew, Y. C., Han, B. et al., (-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells. Carcinogenesis 2011, 32, 1525-1532.
52. Brueckner, B., Lyko, F., DNA methyltransferase inhibitors. Old and new drugs for an epigenetic cancer therapy. Trends Pharmacol. Sci. 2004, 25, 551-554.
53. Grafodatskaya, D., Chung, B., Szatmari, P., Weksberg, R., Autism spectrum disorders and epigenetics. J. Am. Acad. Child Adolesc. Psychiatr. 2010, 49, 794-809.
54. Nephew, K. P., Huang, T. H., Epigenetic gene silencing in cancer initiation and progression. Cancer Lett. 2003, 190, 125-133.
55. Fang, M. Z., Wang, Y., Ai, N., Hou, Z. et al., Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 2003, 63, 7563-7570.
56. Egger, G., Liang, G., Aparicio, A., Jones, P. A., Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004, 429, 457-463.
57. Volpe, T. A., Kidner, C., Hall, I. M., Teng, G. et al., Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 2002, 297, 1833-1837.
58. Wang, Y. H., Liu, S., Zhang, G., Zhou, C. Q. et al., Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Res. 2005, 7, R220-R228.
59. Yavari, K., Taghikhani, M., Ghannadi Maragheh, M., Mesbah-Namin, S. A. et al., Downregulation of IGF-IR expression by RNAi inhibits proliferation and enhances chemosensitization of human colon cancer cells. Int. J. Colorectal Dis. 2010, 25, 9-16.
60. Lujambio, A., Portela, A., Liz, J., Melo, S. A. et al., CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene 2010, 29, 6390-6401.
61. Ducasse, M., Brown, M. A., Epigenetic aberrations and cancer. Mol. Cancer 2006, 5, 60.
62. Zilberman, D., Cao, X., Jacobsen, S. E., ARGONAUTE4 control of locus-specific siRNA accumulation and DNA and histone methylation. Science 2003, 299, 716-719.
63. Martinez, M. A., Gutierrez, A., Armand-Ugon, M., Blanco, J. et al., Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. Aids 2002, 16, 2385-2390.
64. Gerhauser, C., Cancer chemoprevention and nutri-epigenetics: state of the art and future challenges. Topics Curr. Chem. 2013, 329, 73-132.
65. Meja, K. K., Rajendrasozhan, S., Adenuga, D., Biswas, S. K. et al., Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. Am. J. Resp. Cell Mol. Biol. 2008, 39, 312-323.
66. Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B. et al., Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J. Exp. Med. 2006, 203, 7-13.
67. Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D. et al., Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004, 23, 2369-2380.
68. Birrell, M. A., McCluskie, K., Wong, S., Donnelly, L. E. et al., Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism. FASEB J. 2005, 19, 840-841.
69. Murase, T., Haramizu, S., Shimotoyodome, A., Tokimitsu, I. et al., Green tea extract improves running endurance in mice by stimulating lipid utilization during exercise. Am. J. Physiol. Regulat. Integrat. Comparat. Physiol. 2006, 290, R1550-1556.
70. Kim, H. C., Mofarrahi, M., Hussain, S. N., Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int. J. Chronic Obs. Pulmonary Dis. 2008, 3, 637-658.
71. Amat, R., Planavila, A., Chen, S. L., Iglesias, R. et al., SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-gamma Co-activator-1alpha (PGC-1alpha) gene in skeletal muscle through the PGC-1alpha autoregulatory loop and interaction with MyoD. J. Biol. Chem. 2009, 284, 21872-21880.
72. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H. et al., Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127, 1109-1122.
73. Lappalainen, Z., Sirtuins: a family of proteins with implications for human performance and exercise physiology. Res. Sports Med. 2011, 19, 53-65.
74. Nieman, D. C., Williams, A. S., Shanely, R. A., Jin, F. et al., Quercetin's influence on exercise performance and muscle mitochondrial biogenesis. Med. Sci. Sports Exer. 2010, 42, 338-345.
75. Boily, G., He, X. H., Pearce, B., Jardine, K. et al., SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol. Oncogene 2009, 28, 2882-2893.
76. Thakur, V. S., Gupta, K., Gupta, S., Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases. Carcinogenesis 2012, 33, 377-384.
77. Tanno, M., Kuno, A., Yano, T., Miura, T. et al., Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J. Biol. Chem. 2010, 285, 8375-8382.
78. Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F. et al., Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004, 303, 2011-2015.
79. Cho, I. R., Koh, S. S., Malilas, W., Srisuttee, R. et al., SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of beta-catenin. Biochem. Biophys. Res. Commun. 2012, 423, 270-275.
80. Saha, R. N., Pahan, K., HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Different. 2006, 13, 539-550.
81. Stilling, R. M., Fischer, A., The role of histone acetylation in age-associated memory impairment and Alzheimer's disease. Neurobiol. Learn. Memory 2011, 96, 19-26.
82. Sananbenesi, F., Fischer, A., The epigenetic bottleneck of neurodegenerative and psychiatric diseases. Biol. Chem. 2009, 390, 1145-1153.
83. Dash, P. K., Orsi, S. A., Moore, A. N., Histone deactylase inhibition combined with behavioral therapy enhances learning and memory following traumatic brain injury. Neuroscience 2009, 163, 1-8.
84. Zhu, H. R., Wang, Z. Y., Zhu, X. L., Wu, X. X. et al., Icariin protects against brain injury by enhancing SIRT1-dependent PGC-1alpha expression in experimental stroke. Neuropharmacology 2010, 59, 70-76.
85. Kim, S. J., Jeong, H. J., Lee, K. M., Myung, N. Y. et al., Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells. J. Nutr. Biochem. 2007, 18, 587-596.
86. Cornelius, P., MacDougald, O. A., Lane, M. D., Regulation of adipocyte development. Annu. Rev. Nutr. 1994, 14, 99-129.
87. Kadowaki, T., Yamauchi, T., Waki, H., Iwabu, M. et al., Adiponectin, adiponectin receptors, and epigenetic regulation of adipogenesis. Cold Spring Harbor Symp. Quant. Biol. 2011, 76, 257-265.
88. Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A. et al., Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 2004, 429, 771-776.
89. Wang, Q., Liu, M., Liu, W. W., Hao, W. B. et al., In vivo recovery effect of silibinin treatment on streptozotocin-induced diabetic mice is associated with the modulations of Sirt-1 expression and autophagy in pancreatic beta-cell. J. Asian Nat. Prod. Res. 2012, 14, 413-423.
90. Wang, G. L., Fu, Y. C., Xu, W. C., Feng, Y. Q. et al., Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway. Biochem. Biophys. Res. Comm. 2009, 380, 644-649.
91. Yao, H., Chung, S., Hwang, J. W., Rajendrasozhan, S. et al., SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J. Clin. Invest. 2012, 122, 2032-2045.
92. Jones, E., Hughes, R. E., Quercetin, flavonoids and the life-span of mice. Exp. Gerontol. 1982, 17, 213-217.
93. de Boer, V. C., de Goffau, M. C., Arts, I. C., Hollman, P. C. et al., SIRT1 stimulation by polyphenols is affected by their stability and metabolism. Mechan. Ageing Dev. 2006, 127, 618-627.
94. Yokozawa, T., Lee, Y. A., Zhao, Q., Matsumoto, K. et al., Persimmon oligomeric proanthocyanidins extend life span of senescence-accelerated mice. J. Med. Food 2009, 12, 1199-1205.
95. Blackwell, L., Norris, J., Suto, C. M., Janzen, W. P., The use of diversity profiling to characterize chemical modulators of the histone deacetylases. Life Sci. 2008, 82, 1050-1058.
96. Monti, B., Gatta, V., Piretti, F., Raffaelli, S. S. et al., Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein. Neurotox. Res. 2010, 17, 130-141.
97. Fang, M., Chen, D., Yang, C. S., Dietary polyphenols may affect DNA methylation. J. Nutr. 2007, 137, 223S-228S.
98. Collins, H. M., Abdelghany, M. K., Messmer, M., Yue, B. et al., Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells. BMC Cancer 2013, 13, 37.
99. Majid, S., Kikuno, N., Nelles, J., Noonan, E. et al., Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res. 2008, 68, 2736-2744.
100. King-Batoon, A., Leszczynska, J. M., Klein, C. B., Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ. Mol. Mutagen. 2008, 49, 36-45.
101. Lee, Y. A., Cho, E. J., Yokozawa, T., Protective effect of persimmon (Diospyros kaki) peel proanthocyanidin against oxidative damage under H2O2-induced cellular senescence. Biol. Pharm. Bull. 2008, 31, 1265-1269.
102. Papoutsis, A. J., Lamore, S. D., Wondrak, G. T., Selmin, O. I. et al., Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells. J. Nutr. 2010, 140, 1607-1614.
103. Shim, S., Kim, S., Choi, D. S., Kwon, Y. B. et al., Anti-inflammatory effects of [6]-shogaol: potential roles of HDAC inhibition and HSP70 induction. Food Chem. Toxicol. 2011, 49, 2734-2740.
104. Zhu, X., Liu, Q., Wang, M., Liang, M. et al., Activation of Sirt1 by resveratrol inhibits TNF-alpha induced inflammation in fibroblasts. PloS one 2011, 6, e27081.
105. Tseng, P. C., Hou, S. M., Chen, R. J., Peng, H. W. et al., Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis. J. Bone Min. Res. 2011, 26, 2552-2563.
106. Mukherjee, S., Ray, D., Lekli, I., Bak, I. et al., Effects of Longevinex (modified resveratrol) on cardioprotection and its mechanisms of action. Can. J. Physiol. Pharmacol. 2010, 88, 1017-1025.
107. Wang, S., Song, P., Zou, M. H., Inhibition of AMP-activated protein kinase alpha (AMPKalpha) by doxorubicin accentuates genotoxic stress and cell death in mouse embryonic fibroblasts and cardiomyocytes: role of p53 and SIRT1. J. Biol. Chem. 2012, 287, 8001-8012.
108. Yi, J., Luo, J., SIRT1 and p53, effect on cancer, senescence and beyond. Biochim. Biophys. Acta 2010, 1804, 1684-1689.
109. Wang, F., Chan, C. H., Chen, K., Guan, X. et al., Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation. Oncogene 2012, 31, 1546-1557.
110. Kwon, I. K., Wang, R., Thangaraju, M., Shuang, H. et al., PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4. Oncogene 2010, 29, 3423-3434.
111. Bourguignon, L. Y., Xia, W., Wong, G., Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells. J. Biol. Chem. 2009, 284, 2657-2671.